
Home Blood Testing Devices Market Report and Forecast 2025-2034
Description
The global home blood testing devices market size was valued at USD 16.40 Billion in 2024, driven by the rising prevalence of diabetes across the globe. The market is expected to grow at a CAGR of 10.70% during the forecast period of 2025-2034, with the values likely to rise from USD 45.32 Billion by 2034.
Home Blood Testing Devices: Introduction
Home blood testing devices are portable medical devices used to monitor blood glucose levels in people who are diabetic, and other tests such as cholesterol levels, blood pressure, hemoglobin levels, and more. The tests are performed by taking blood samples with the help of test strips or cartridges (usually comes with the device kit). The advantage of using home blood testing devices is the ability to monitor health conditions of an individual in real-time, early detection of abnormalities or changes in blood parameters, and the convenience of testing at home without the need to visit a healthcare facility.
Global Home Blood Testing Devices Market Analysis
The home blood testing devices market demand is driven by the increased application and demand of at home devices. Due to the changing lifestyles and increasing health expenditures, people now prefer self-performing activities that could be performed without the presence of a healthcare professional. Hence, the demand for home blood testing devices has increased.
The increasing technological advancement in the development of home blood testing devices to acquire accurate and reliable results is also driving the market growth globally. The practice to reduce the size of these devices is also going on with the integration of digital platforms to manage the data and analyze it in real time. In August 2023, Vital Bio unveiled their new product VitalOne, that could interpret the test results of smaller blood samples in just 20 minutes. Such technologies are contributing to market growth significantly.
The increasing integration of home blood testing devices with wearable devices, such as smartwatches and fitness trackers, is also gaining popularity and driving the market growth. With the help of this integration continuous monitoring of health parameters and seamless data sharing between devices is possible which enhances the overall healthcare experience for individuals.
There is a significant rise in the home blood testing devices market value with the arrival novel technologies like bloodless blood tests in the market. General Prognostics is developing the potentially lifesaving bloodless blood tests technology that detects the changing trends in a patient’s body, even before they show symptoms. Based on artificial intelligence (AI), such tests utilise digital biomarkers with blood biomarkers to provide timely, clinically significant information about the condition of heart failure patients.
Global Home Blood Testing Devices Market Segmentation
Home Blood Testing Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
With the rising prevalence of chronic diseases, North America, especially the United States, has led the home blood testing devices market share in the historical period. The increased focus on preventive healthcare and well-equipped infrastructure to adapt with the technological advancements have majorly driven the market growth.
In Europe, owing to the increased efforts of the government and influential healthcare companies, at home blood testing has become normal in common households. With a robust healthcare ecosystem, the region is a major consumer of such testing devices and is estimated to have a large market share in the forecast period as well.
To meet the high home blood testing devices market demand, the companies present in the Asia-Pacific region have boosted the production of such devices. With a substantial portion of geriatric population, the region is witnessing a high number of cholesterol level, hemoglobin, blood pressure level testing. In addition, the governments are also proactive in spreading awareness and educating the population about the benefits and application of these tools.
Global Home Blood Testing Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Home Blood Testing Devices: Introduction
Home blood testing devices are portable medical devices used to monitor blood glucose levels in people who are diabetic, and other tests such as cholesterol levels, blood pressure, hemoglobin levels, and more. The tests are performed by taking blood samples with the help of test strips or cartridges (usually comes with the device kit). The advantage of using home blood testing devices is the ability to monitor health conditions of an individual in real-time, early detection of abnormalities or changes in blood parameters, and the convenience of testing at home without the need to visit a healthcare facility.
Global Home Blood Testing Devices Market Analysis
The home blood testing devices market demand is driven by the increased application and demand of at home devices. Due to the changing lifestyles and increasing health expenditures, people now prefer self-performing activities that could be performed without the presence of a healthcare professional. Hence, the demand for home blood testing devices has increased.
The increasing technological advancement in the development of home blood testing devices to acquire accurate and reliable results is also driving the market growth globally. The practice to reduce the size of these devices is also going on with the integration of digital platforms to manage the data and analyze it in real time. In August 2023, Vital Bio unveiled their new product VitalOne, that could interpret the test results of smaller blood samples in just 20 minutes. Such technologies are contributing to market growth significantly.
The increasing integration of home blood testing devices with wearable devices, such as smartwatches and fitness trackers, is also gaining popularity and driving the market growth. With the help of this integration continuous monitoring of health parameters and seamless data sharing between devices is possible which enhances the overall healthcare experience for individuals.
There is a significant rise in the home blood testing devices market value with the arrival novel technologies like bloodless blood tests in the market. General Prognostics is developing the potentially lifesaving bloodless blood tests technology that detects the changing trends in a patient’s body, even before they show symptoms. Based on artificial intelligence (AI), such tests utilise digital biomarkers with blood biomarkers to provide timely, clinically significant information about the condition of heart failure patients.
Global Home Blood Testing Devices Market Segmentation
Home Blood Testing Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Glucose Test Kits
- Infectious Diseases Test Kits
- Cholesterol Test Strips
- Drugs of Abuse Test Kits
- Coagulation Monitoring Tests
- Others
- Pediatric
- Adult
- Geriatric
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
With the rising prevalence of chronic diseases, North America, especially the United States, has led the home blood testing devices market share in the historical period. The increased focus on preventive healthcare and well-equipped infrastructure to adapt with the technological advancements have majorly driven the market growth.
In Europe, owing to the increased efforts of the government and influential healthcare companies, at home blood testing has become normal in common households. With a robust healthcare ecosystem, the region is a major consumer of such testing devices and is estimated to have a large market share in the forecast period as well.
To meet the high home blood testing devices market demand, the companies present in the Asia-Pacific region have boosted the production of such devices. With a substantial portion of geriatric population, the region is witnessing a high number of cholesterol level, hemoglobin, blood pressure level testing. In addition, the governments are also proactive in spreading awareness and educating the population about the benefits and application of these tools.
Global Home Blood Testing Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ACON Laboratories Inc
- Quidel Corporation
- OraSure Technologies Inc
- Cardinal Health Inc
- PHC Holdings Corporation
- B. Braun Melsungen AG
- Abbott Laboratories
- Biomerieux SA
- F. Hoffmann-La-Roche Ltd
- Everly Health Inc
- Walgreens
- D&A health
- Pts Disgnostics
- Trinity Biotech Plc
- Siemens Healthineers
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Home Blood Testing Devices Market Overview
- 3.1 Global Home Blood Testing Devices Market Historical Value (2018-2024)
- 3.2 Global Home Blood Testing Devices Market Forecast Value (2025-2034)
- 4 Global Home Blood Testing Devices Market Landscape
- 4.1 Global Home Blood Testing Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Home Blood Testing Devices Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Home Blood Testing Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Home Blood Testing Devices Market Segmentation
- 6.1 Global Home Blood Testing Devices Market by Type
- 6.1.1 Market Overview
- 6.1.2 Glucose Test Kits
- 6.1.3 Infectious Diseases Test Kits
- 6.1.4 Cholesterol Test Strips
- 6.1.5 Drugs of Abuse Test Kits
- 6.1.6 Coagulation Monitoring Tests
- 6.1.7 Others
- 6.2 Global Home Blood Testing Devices Market by Age Group
- 6.2.1 Market Overview
- 6.2.2 Pediatric
- 6.2.3 Adult
- 6.2.4 Geriatric
- 6.3 Global Home Blood Testing Devices Market by Distribution Channel
- 6.3.1 Market Overview
- 6.3.2 Hospital Pharmacy
- 6.3.3 Retail Pharmacy
- 6.3.4 Online Pharmacy
- 6.3.5 Others
- 6.4 Global Home Blood Testing Devices Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Home Blood Testing Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Home Blood Testing Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Home Blood Testing Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Home Blood Testing Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Home Blood Testing Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 ACON Laboratories Inc
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Quidel Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 OraSure Technologies Inc
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Cardinal Health Inc
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 PHC Holdings Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 B. Braun Melsungen AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Abbott Laboratories
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Biomerieux SA
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 F. Hoffmann-La-Roche Ltd
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Everly Health Inc
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Walgreens
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 D&A health
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Pts Disgnostics
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Trinity Biotech Plc
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Siemens Healthineers
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Home Blood Testing Devices Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.